Interpretation of Clinical Research Result of Danoprevir-based Antiviral Regimen in the Treatment of Chronic Hepatitis C Published in Chin J Infect Dis

Ascletis to Present at the 17th Annual Morgan Stanley Asia Pacific Summit

Ascletis and Roche Enter Exclusive Pegasys Partnership in China for Viral Hepatitis

Ascletis Appoints Dr. Lindi Tan as Chief Financial Officer

Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD